- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Oral Polio Vaccines (OPV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Oral Polio Vaccines (OPV) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Public accounting for % of the Oral Polio Vaccines (OPV) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Trivalent OPV segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Polio Vaccines (OPV) include Sanofi, GSK, Bibcol, Serum Institute, and Tiantan Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Polio Vaccines (OPV) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Trivalent OPV
Bivalent OPV
Market segment by Application can be divided into
Public
Private
The key market players for global Oral Polio Vaccines (OPV) market are listed below:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Polio Vaccines (OPV) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Polio Vaccines (OPV), with price, sales, revenue and global market share of Oral Polio Vaccines (OPV) from 2019 to 2022.
Chapter 3, the Oral Polio Vaccines (OPV) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Polio Vaccines (OPV) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Polio Vaccines (OPV) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Polio Vaccines (OPV).
Chapter 13, 14, and 15, to describe Oral Polio Vaccines (OPV) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Oral Polio Vaccines (OPV) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Polio Vaccines (OPV) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Trivalent OPV
1.2.3 Bivalent OPV
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Polio Vaccines (OPV) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public
1.3.3 Private
1.4 Global Oral Polio Vaccines (OPV) Market Size & Forecast
1.4.1 Global Oral Polio Vaccines (OPV) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Polio Vaccines (OPV) Sales in Volume (2017-2028)
1.4.3 Global Oral Polio Vaccines (OPV) Price (2017-2028)
1.5 Global Oral Polio Vaccines (OPV) Production Capacity Analysis
1.5.1 Global Oral Polio Vaccines (OPV) Total Production Capacity (2017-2028)
1.5.2 Global Oral Polio Vaccines (OPV) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Polio Vaccines (OPV) Market Drivers
1.6.2 Oral Polio Vaccines (OPV) Market Restraints
1.6.3 Oral Polio Vaccines (OPV) Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Oral Polio Vaccines (OPV) Product and Services
2.1.4 Sanofi Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Oral Polio Vaccines (OPV) Product and Services
2.2.4 GSK Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Oral Polio Vaccines (OPV) Product and Services
2.3.4 Bibcol Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Oral Polio Vaccines (OPV) Product and Services
2.4.4 Serum Institute Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
2.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Panacea Biotec Ltd
2.6.1 Panacea Biotec Ltd Details
2.6.2 Panacea Biotec Ltd Major Business
2.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
2.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bio-Med
2.7.1 Bio-Med Details
2.7.2 Bio-Med Major Business
2.7.3 Bio-Med Oral Polio Vaccines (OPV) Product and Services
2.7.4 Bio-Med Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Halfkin Bio-Pharmaceuticals
2.8.1 Halfkin Bio-Pharmaceuticals Details
2.8.2 Halfkin Bio-Pharmaceuticals Major Business
2.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
2.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Polio Vaccines (OPV) Breakdown Data by Manufacturer
3.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Polio Vaccines (OPV) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Polio Vaccines (OPV)
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Polio Vaccines (OPV) Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Polio Vaccines (OPV) Manufacturer Market Share in 2021
3.5 Global Oral Polio Vaccines (OPV) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Polio Vaccines (OPV) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Polio Vaccines (OPV) Market Size by Region
4.1.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Polio Vaccines (OPV) Revenue by Region (2017-2028)
4.2 North America Oral Polio Vaccines (OPV) Revenue (2017-2028)
4.3 Europe Oral Polio Vaccines (OPV) Revenue (2017-2028)
4.4 Asia-Pacific Oral Polio Vaccines (OPV) Revenue (2017-2028)
4.5 South America Oral Polio Vaccines (OPV) Revenue (2017-2028)
4.6 Middle East and Africa Oral Polio Vaccines (OPV) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Type (2017-2028)
5.2 Global Oral Polio Vaccines (OPV) Revenue by Type (2017-2028)
5.3 Global Oral Polio Vaccines (OPV) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Application (2017-2028)
6.2 Global Oral Polio Vaccines (OPV) Revenue by Application (2017-2028)
6.3 Global Oral Polio Vaccines (OPV) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
7.2 North America Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
7.3 North America Oral Polio Vaccines (OPV) Market Size by Country
7.3.1 North America Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
8.2 Europe Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
8.3 Europe Oral Polio Vaccines (OPV) Market Size by Country
8.3.1 Europe Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Polio Vaccines (OPV) Market Size by Region
9.3.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Polio Vaccines (OPV) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
10.2 South America Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
10.3 South America Oral Polio Vaccines (OPV) Market Size by Country
10.3.1 South America Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Polio Vaccines (OPV) Market Size by Country
11.3.1 Middle East & Africa Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Polio Vaccines (OPV) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Polio Vaccines (OPV)
12.3 Oral Polio Vaccines (OPV) Production Process
12.4 Oral Polio Vaccines (OPV) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Polio Vaccines (OPV) Typical Distributors
13.3 Oral Polio Vaccines (OPV) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Oral Polio Vaccines (OPV) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Polio Vaccines (OPV) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Oral Polio Vaccines (OPV) Product and Services
Table 6. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Oral Polio Vaccines (OPV) Product and Services
Table 10. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
Table 12. Bibcol Major Business
Table 13. Bibcol Oral Polio Vaccines (OPV) Product and Services
Table 14. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 16. Serum Institute Major Business
Table 17. Serum Institute Oral Polio Vaccines (OPV) Product and Services
Table 18. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Major Business
Table 21. Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
Table 22. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Panacea Biotec Ltd Major Business
Table 25. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
Table 26. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 28. Bio-Med Major Business
Table 29. Bio-Med Oral Polio Vaccines (OPV) Product and Services
Table 30. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Halfkin Bio-Pharmaceuticals Major Business
Table 33. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
Table 34. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Oral Polio Vaccines (OPV) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 36. Global Oral Polio Vaccines (OPV) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Oral Polio Vaccines (OPV), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Oral Polio Vaccines (OPV) Production Capacity by Company, (M Doses): 2020 VS 2021
Table 39. Head Office and Oral Polio Vaccines (OPV) Production Site of Key Manufacturer
Table 40. Oral Polio Vaccines (OPV) New Entrant and Capacity Expansion Plans
Table 41. Oral Polio Vaccines (OPV) Mergers & Acquisitions in the Past Five Years
Table 42. Global Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 43. Global Oral Polio Vaccines (OPV) Sales by Region (2023-2028) & (M Doses)
Table 44. Global Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Oral Polio Vaccines (OPV) Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 47. Global Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 48. Global Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Oral Polio Vaccines (OPV) Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Oral Polio Vaccines (OPV) Price by Type (2017-2022) & (USD/Doses)
Table 51. Global Oral Polio Vaccines (OPV) Price by Type (2023-2028) & (USD/Doses)
Table 52. Global Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 53. Global Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 54. Global Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Oral Polio Vaccines (OPV) Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Oral Polio Vaccines (OPV) Price by Application (2017-2022) & (USD/Doses)
Table 57. Global Oral Polio Vaccines (OPV) Price by Application (2023-2028) & (USD/Doses)
Table 58. North America Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 59. North America Oral Polio Vaccines (OPV) Sales by Country (2023-2028) & (M Doses)
Table 60. North America Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Oral Polio Vaccines (OPV) Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 63. North America Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 64. North America Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 65. North America Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 66. Europe Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 67. Europe Oral Polio Vaccines (OPV) Sales by Country (2023-2028) & (M Doses)
Table 68. Europe Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Oral Polio Vaccines (OPV) Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 71. Europe Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 72. Europe Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 73. Europe Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 74. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 75. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Region (2023-2028) & (M Doses)
Table 76. Asia-Pacific Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Oral Polio Vaccines (OPV) Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 79. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 80. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 81. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 82. South America Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 83. South America Oral Polio Vaccines (OPV) Sales by Country (2023-2028) & (M Doses)
Table 84. South America Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Oral Polio Vaccines (OPV) Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 87. South America Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 88. South America Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 89. South America Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 90. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 91. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Region (2023-2028) & (M Doses)
Table 92. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 95. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 96. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 97. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 98. Oral Polio Vaccines (OPV) Raw Material
Table 99. Key Manufacturers of Oral Polio Vaccines (OPV) Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Oral Polio Vaccines (OPV) Typical Distributors
Table 103. Oral Polio Vaccines (OPV) Typical Customers
List of Figures
Figure 1. Oral Polio Vaccines (OPV) Picture
Figure 2. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type in 2021
Figure 3. Trivalent OPV
Figure 4. Bivalent OPV
Figure 5. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application in 2021
Figure 6. Public
Figure 7. Private
Figure 8. Global Oral Polio Vaccines (OPV) Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 9. Global Oral Polio Vaccines (OPV) Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Oral Polio Vaccines (OPV) Sales (2017-2028) & (M Doses)
Figure 11. Global Oral Polio Vaccines (OPV) Price (2017-2028) & (USD/Doses)
Figure 12. Global Oral Polio Vaccines (OPV) Production Capacity (2017-2028) & (M Doses)
Figure 13. Global Oral Polio Vaccines (OPV) Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Oral Polio Vaccines (OPV) Market Drivers
Figure 15. Oral Polio Vaccines (OPV) Market Restraints
Figure 16. Oral Polio Vaccines (OPV) Market Trends
Figure 17. Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturer in 2021
Figure 18. Global Oral Polio Vaccines (OPV) Revenue Market Share by Manufacturer in 2021
Figure 19. Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Oral Polio Vaccines (OPV) Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Oral Polio Vaccines (OPV) Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2028)
Figure 23. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2028)
Figure 24. North America Oral Polio Vaccines (OPV) Revenue (2017-2028) & (USD Million)
Figure 25. Europe Oral Polio Vaccines (OPV) Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Oral Polio Vaccines (OPV) Revenue (2017-2028) & (USD Million)
Figure 27. South America Oral Polio Vaccines (OPV) Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Oral Polio Vaccines (OPV) Revenue (2017-2028) & (USD Million)
Figure 29. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 30. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
Figure 31. Global Oral Polio Vaccines (OPV) Price by Type (2017-2028) & (USD/Doses)
Figure 32. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 33. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
Figure 34. Global Oral Polio Vaccines (OPV) Price by Application (2017-2028) & (USD/Doses)
Figure 35. North America Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 36. North America Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 37. North America Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2028)
Figure 38. North America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2028)
Figure 39. United States Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 43. Europe Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 44. Europe Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2028)
Figure 45. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2028)
Figure 46. Germany Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2028)
Figure 55. China Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 62. South America Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 63. South America Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2028)
Figure 64. South America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Oral Polio Vaccines (OPV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Oral Polio Vaccines (OPV) in 2021
Figure 76. Manufacturing Process Analysis of Oral Polio Vaccines (OPV)
Figure 77. Oral Polio Vaccines (OPV) Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
